AstraZeneca COVID-19 Vaccine Linked To Rare Blood Clot: Canada Set To Throw Million of Doses Over Fatal Side Effects
Oxford-AstraZeneca COVID-19 vaccine is a two-dose vaccine which has been jointly developed by the Oxford Vaccine Group and pharmaceutical company AstraZeneca to target the SARS-CoV-2 virus.